We recently published a list of 10 Stocks With At Least $20 Million In Insider Spending Recently. In this article, we are ...

We recently published a list of 10 Stocks With At Least $10 Million In Insider Spending Recently. In this article, we are ...

Metsera and Maze Therapeutics have become the second and third biotechs to complete an initial public offering (IPO) on the Nasdaq this year, raising $275 million and $140 million, respectively.

Its prospectus says that the IPO will fund phase 1 and phase 2a proof ... The two filings follow in the footsteps of obesity drug developer Metsera and genetic medicines developer Maze ...

The newly listed clinical-stage biotechnology company, Metsera Inc. rose 15.01% on Monday as the broader markets declined.

Discover key insights from Amneal Pharmaceuticals' Q4 2024 earnings, including revenue growth, CREXONT's market success, and biosimilar expansion.

Key strategic actions included the launch of CREXONT, entry into the GLP-1 market through a collaboration with Metsera, and expansion of the biosimilars pipeline. CREXONT, a treatment for ...

After hours: 7:03:24 p.m. EST ...

2-Year U.S. Treasury Note Continuous Contract $103.465-0.039-0.04% 5-Year U.S. Treasury Note Continuous Contract $107.734-0.086-0.08% 10-Year U.S. Treasury Note Continuous Contract $110.781-0.094 ...